基于影像组学的机器学习术前预测临床IA期纯实性非小细胞肺癌生存结局
本研究回顾性纳入2012年1月至2020年12月接受肺切除术的642例临床IA期纯实性非小细胞肺癌患者,利用术前临床和影像组学特征构建随机生存森林和XGBoost机器学习模型预测总生存,并与Cox回归基准比较。XGBoost模型表现最佳(iAUC 0.832,95%CI 0.779-0.880),并将患者分为低危(5年OS 100.0%)、中低危(88.5%)、中高危(75.6%)和高危(41.7%)四组,组间OS差异显著(P < .0001)。
要点
- XGBoost模型预测总生存的iAUC为0.832(95%CI 0.779-0.880),优于随机生存森林和Cox回归。
- 模型将患者分为四组,5年OS分别为100.0%、88.5%、75.6%和41.7%(P < .0001)。
- 基于影像组学的机器学习模型可术前准确预测OS并改善生存分层。
核心结论
- 基于影像组学的机器学习模型可术前准确预测临床IA期纯实性非小细胞肺癌的总生存并改善生存分层。
研究设计与样本
- 回顾性队列研究,纳入2012年1月至2020年12月接受肺切除术的642例临床IA期纯实性非小细胞肺癌患者。
- 从肿瘤内和瘤周区域的CT图像提取影像组学特征,使用随机生存森林和XGBoost算法构建机器学习模型,以Cox回归模型为基准。
- 模型性能用积分时间依赖曲线下面积(iAUC)评估,并通过5折交叉验证验证。
主要发现
- 从3748个影像组学特征和34个术前临床特征中筛选出42个特征。
- 两个机器学习模型均优于Cox回归模型(iAUC 0.753,95%CI 0.629-0.829)。
- XGBoost模型性能(iAUC 0.832,95%CI 0.779-0.880)优于随机生存森林模型(iAUC 0.795,95%CI 0.734-0.856)。
- XGBoost模型生存分层表现优异,低危组5年OS 100.0%、中低危组88.5%、中高危组75.6%、高危组41.7%,组间差异显著(P < .0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Clinical stage IA non-small cell lung cancer (NSCLC) showing a pure-solid appearance on computed tomography is associated with a worse prognosis. This study aimed to develop and validate machine-learning models using preoperative clinical and radiomic features to predict overall survival (OS) in clinical stage IA pure-solid NSCLC. METHODS: Patients who underwent lung resection for NSCLC between January 2012 and December 2020 were reviewed. The radiomic features were extracted from the intratumoral and peritumoral regions on computed tomography. The machine-learning models were developed using random survival forest and eXtreme Gradient Boosting (XGBoost) algorithms, whereas the Cox regression model was set as a benchmark. Model performance was assessed using the integrated time-dependent area under the curve (iAUC) and validated by 5-fold cross-validation. RESULTS: In total, 642 patients with clinical stage IA pure-solid NSCLC were included. Among 3748 radiomic and 34 preoperative clinical features, 42 features were selected. Both machine-learning models outperformed the Cox regression model (iAUC, 0.753; 95% confidence interval [CI], 0.629-0.829). The XGBoost model showed a better performance (iAUC, 0.832; 95% CI, 0.779-0.880) than the random survival forest model (iAUC, 0.795; 95% CI, 0.734-0.856). The XGBoost model showed an excellent survival stratification performance with a significant OS difference among the low-risk (5-year OS, 100.0%), moderate low-risk (5-year OS, 88.5%), moderate high-risk (5-year OS, 75.6%), and high-risk (5-year OS, 41.7%) groups (P < .0001). CONCLUSIONS: A radiomics-based machine-learning model can preoperatively and accurately predict OS and improve survival stratification in clinical stage IA pure-solid NSCLC.
引用
- Yan H, Niimi T, Matsunaga T, et al. Preoperatively predicting survival outcome for clinical stage IA pure-solid non-small cell lung cancer by radiomics-based machine learning. J Thorac Cardiovasc Surg. 2024. PMID: 38788833. doi:10.1016/j.jtcvs.2024.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。